sur WHO Foundation
Boehringer Ingelheim and WHO Foundation Unite to Tackle Obesity
Boehringer Ingelheim and the WHO Foundation have announced a global initiative to address obesity and metabolic health issues. A significant USD 5 million, pledged over three years, will support this endeavor. This collaboration focuses on integrated care for obesity and diseases such as cardiovascular, kidney, liver, and metabolic disorders, improving outcomes worldwide.
Obesity remains a major health challenge, with over 2.5 billion adults and 390 million children affected globally by 2022. The initiative aims to strengthen health systems, ensuring preparedness and comprehensive care for obesity-related conditions. It emphasizes cross-sector collaboration and patient-centered care.
The WHO Foundation will back WHO's Acceleration Plan to Stop Obesity, promoting intervention and systemic change. By linking obesity care with related diseases, the aim is to foster lasting, equitable chronic care within resilient healthcare systems worldwide.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de WHO Foundation